Profile
| Metric | Value |
|---|---|
| Full Name | Bicara Therapeutics Inc. |
| Ticker | NASDAQ: BCAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | bicara.com |
| Employees | 55 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $16.37 | |
| Price, 1D Change | -3.76% | |
| $897M | ||
| - | ||
| - | ||
| 1.44 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.25 | ||
| EPS, 1Y Change | -24.37% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.25 | ||
| EPS Estimate | -$2.48 | |
| EPS Est. Change | -98.56% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $16.37 | |
| Price Target | - | $30.50 |
| Price Tgt. Change | - | +86.32% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.64 | -$1.25 | +52.73% | |
| -$2.48 | N/A | -98.56% | |
| -$2.96 | N/A | -137.07% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $16.37 | |
| $13.96 | ||
| SMA 200 vs Price | -14.73% | |
| $17.48 | ||
| SMA 50 vs Price | +6.80% | |
| 1.44 | ||
| $1.01 | ||
| 44.60 | ||
| 42.82% | ||
| 86.42% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.25 | ||
| -$56.00K | ||
| - | ||
| -$82.39M | ||
| - | ||
| -$68.00M | ||
| - | ||
| -$82.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 27.93 | ||
| 27.93 | ||
| - | ||
| - | ||
| 6.96 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.23 | ||
| -4.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $491.88M | ||
| $489.71M | ||
| $569.20M | ||
| $502.53M | ||
| $77.32M | ||
| $17.99M | ||
| $738.00K | ||
| $607.00K | ||
| $4.51M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $82.39M | ||
| $82.39M | ||
| $56.00K | ||
| $18.77M | ||
| $56.00K | ||
| $0.00 | ||
| $187.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$74.75M | ||
| -$9,000.00 | ||
| $334.03M | ||
| $71.00K | ||
| -$74.82M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citizens | ||
| Wedbush | → | |
| BTIG | ||
| Mizuho | ||
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | ||
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo |
Analyst sentiment
Institutional ownership
Screeners with BCAX
FAQ
What is the ticker symbol for Bicara Therapeutics Inc.?
The ticker symbol for Bicara Therapeutics Inc. is NASDAQ:BCAX
Does Bicara Therapeutics Inc. pay dividends?
No, Bicara Therapeutics Inc. does not pay dividends
What sector is Bicara Therapeutics Inc. in?
Bicara Therapeutics Inc. is in the Healthcare sector
What industry is Bicara Therapeutics Inc. in?
Bicara Therapeutics Inc. is in the Biotechnology industry
What country is Bicara Therapeutics Inc. based in?
Bicara Therapeutics Inc. is headquartered in United States
When did Bicara Therapeutics Inc. go public?
Bicara Therapeutics Inc. initial public offering (IPO) was on September 13, 2024
Is Bicara Therapeutics Inc. in the S&P 500?
No, Bicara Therapeutics Inc. is not included in the S&P 500 index
Is Bicara Therapeutics Inc. in the NASDAQ 100?
No, Bicara Therapeutics Inc. is not included in the NASDAQ 100 index
Is Bicara Therapeutics Inc. in the Dow Jones?
No, Bicara Therapeutics Inc. is not included in the Dow Jones index
When was Bicara Therapeutics Inc. last earnings report?
Bicara Therapeutics Inc.'s most recent earnings report was on November 10, 2025
When does Bicara Therapeutics Inc. report earnings?
The next expected earnings date for Bicara Therapeutics Inc. is March 26, 2026
Data Sources & References
- BCAX Official Website www.bicara.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2023658/000202365825000109/0002023658-25-000109-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2023658/000202365825000012/0002023658-25-000012-index.htm
- BCAX Profile on Yahoo Finance finance.yahoo.com/quote/BCAX
- BCAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bcax